Skip to content

Line Blot Assay for Anticardiolipin Antibodies (Qualitative)

Published: August 9, 2026Updated: August 16, 2026

This test detects antibodies in your blood that may be linked to certain autoimmune or blood-clotting disorders.

Quick summary

["A simple blood test to check for specific antibodies that could affect your immune system or blood health."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
88743-0
Short code
Zic4 Ab Ser Line blot-aCnc
Synonyms
Zic4 Ab Ser Line blot-aCnc
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
line-blot
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms like unexplained blood clots, unusual bleeding, or autoimmune conditions such as lupus or antiphospholipid syndrome. It could also be used as part of a broader evaluation for unexplained complications or recurrent pregnancy loss.

How the Test Works

The line blot assay uses a specific method to identify anticardiolipin antibodies in your blood. A sample of your blood is tested to see if it reacts with cardiolipin proteins, which are found in certain blood cells and tissues. If antibodies are present, they will bind to the cardiolipin on the test strip, creating a visible line.

Sample Collection and Preparation

You will have a small amount of blood drawn from a vein, usually in your arm. The blood sample is then sent to a lab for processing and testing. This test typically requires a single blood draw and does not require fasting.

What to Expect Before the Test

No special preparation is needed for this test. You may have some mild discomfort or bruising at the injection site, but this usually goes away quickly. If you are on blood-thinning medications, let your healthcare provider know before the test.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

Anticardiolipin Antibodies (Qualitative Line Blot)

Frequently asked questions

What Does a Positive or Negative Result Mean?
A positive result means your blood contains antibodies against cardiolipin, which may suggest an increased risk for blood clotting or autoimmune activity. This does not always mean you have a specific condition, but it may lead to additional testing or monitoring.
Will I Need Follow-Up Tests?
If your results are positive, your healthcare provider may order additional tests to better understand your condition, such as other antibody tests or blood clotting studies. They will also consider your symptoms and medical history to guide next steps.
Can I Take Blood-Thinning Medications After This Test?
Yes, you can continue taking your blood-thinning medications as prescribed. However, always inform your healthcare provider before starting or stopping any medication, especially if you have a positive result, as it may affect your treatment plan.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy